229 related articles for article (PubMed ID: 9378965)
1. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).
Mongini PK; Vilensky MA; Highet PF; Inman JK
J Immunol; 1997 Oct; 159(8):3782-91. PubMed ID: 9378965
[TBL] [Abstract][Full Text] [Related]
2. Membrane IgM-stimulated human B lymphocytes succumb to activation-related apoptosis at a G1-->S transition: influence of ligand affinity and valency.
Mongini PK; Vilensky MA; Highet PF; Inman JK
Cell Immunol; 1998 Sep; 188(2):137-50. PubMed ID: 9756644
[TBL] [Abstract][Full Text] [Related]
3. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
Mongini PK; Highet PF; Inman JK
J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
[TBL] [Abstract][Full Text] [Related]
4. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands.
Mongini PK; Blessinger CA; Dalton JP
J Immunol; 1991 Mar; 146(6):1791-800. PubMed ID: 2005379
[TBL] [Abstract][Full Text] [Related]
5. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
6. Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4.
Mongini PK; Tolani S; Fattah RJ; Inman JK
Cell Immunol; 2002; 216(1-2):50-64. PubMed ID: 12381350
[TBL] [Abstract][Full Text] [Related]
7. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
9. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
10. Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation.
Chakravarty L; Zabel MD; Weis JJ; Weis JH
Int Immunol; 2002 Feb; 14(2):139-46. PubMed ID: 11809733
[TBL] [Abstract][Full Text] [Related]
11. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
12. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
Mongini PK; Blessinger C; Posnett DN; Rudich SM
J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
[TBL] [Abstract][Full Text] [Related]
13. Expression of complement receptor 2 (CD21), membrane IgM and the inhibitory receptor CD32 (FcgammaRIIb) in the lymphoid tissues of neonatal calves.
Chattha KS; Firth MA; Hodgins DC; Shewen PE
Vet Immunol Immunopathol; 2010 Sep; 137(1-2):99-108. PubMed ID: 20488561
[TBL] [Abstract][Full Text] [Related]
14. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
Mongini PK; Blessinger CA; Highet PF; Inman JK
J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
[TBL] [Abstract][Full Text] [Related]
15. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
16. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
[TBL] [Abstract][Full Text] [Related]
17. CD21 augments antigen presentation in immune individuals.
Boackle SA; Holers VM; Karp DR
Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
19. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex.
Mongini PK; Inman JK
Cell Immunol; 2001 Feb; 207(2):127-40. PubMed ID: 11243702
[TBL] [Abstract][Full Text] [Related]
20. Genetic CD21 deficiency is associated with hypogammaglobulinemia.
Thiel J; Kimmig L; Salzer U; Grudzien M; Lebrecht D; Hagena T; Draeger R; Voelxen N; Bergbreiter A; Jennings S; Gutenberger S; Aichem A; Illges H; Hannan JP; Kienzler AK; Rizzi M; Eibel H; Peter HH; Warnatz K; Grimbacher B; Rump JA; Schlesier M
J Allergy Clin Immunol; 2012 Mar; 129(3):801-810.e6. PubMed ID: 22035880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
